New clinical trial designs applied to the study of orphan and rare diseases: feasibility of methodological guidance to clinical development of new treatments from a regulatory perspective

Related content

• Research output

• Applicability and added value of novel methods to improve drug development in rare diseases

  Research output: Contribution to journal › Article › Research

• Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties

  Research output: Contribution to journal › Article › Research › peer-review

• Rare disease registries: Potential applications towards impact on development of new drug treatments

  Research output: Contribution to journal › Article › Research › peer-review